How do you pay?

How to pay the least

Lowest posted price

$249 a month

Jardiance from Boehringer Ingelheim, without insurance.

  1. Sign up for Boehringer Ingelheim Direct self-pay. Or call 1-866-279-8990.Sign up on boehringer-ingelheim.com 
  2. Have your prescriber send the prescription to the program’s pharmacy. It mails the medicine to you.

Free from the maker, if you qualify Boehringer Ingelheim Cares Foundation Patient Assistance Program. Or call 1-800-556-8317.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameJardiance
Authorized genericempagliflozin
Regular genericempagliflozin
What you’d pay
Cash price$249a month from the maker
Not soldThere isn’t one
Not soldNone sold yet
Same as Jardiance?
The original
–
–

Brand nameThe maker’s card

JARDIANCE Savings Card

Savings card from Boehringer Ingelheim

No insurance $249 a month, from Boehringer Ingelheim Direct self-pay
Insurance · as little as $0 for a 30- to 90-day prescription

Sign up on patient.boehringer-ingelheim.com 

Or call 1-866-279-8990.

In the maker’s words

“With the CARECONNECT4ME PATIENT SUPPORT PROGRAM, patients can pay as little as $0 for a 30- to 90-day prescription if eligible. JARDIANCE Savings Card benefits continue as long as patients still qualify (savings subject to monthly limits), so you can keep saving money on JARDIANCE.”

“For eligible patients, Cash/Self-pay is $249 for a 30-day prescription fill.”

From the maker’s offer on patient.boehringer-ingelheim.com, checked October 23, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s price above. You can usually use one or the other on a fill, not both.

Brand nameWith a free discount coupon

Optum Perks, Optum’s free discount coupon, lists these prices for Jardiance without insurance. Show the coupon from its page at the pharmacy; it can’t be used with insurance.

From Optum Perks, read November 2, 2026, with no location set. Its page opens on this dose; other doses and pharmacies near you are priced there too. With insurance, check your co-pay first: it may be lower.

Authorized genericNot sold

There isn’t one. An authorized generic is Jardiance itself, from the same company, sold without the brand name, and usually for less. For now Jardiance is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

JARDIANCE is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated:

  • To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
  • To reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression.
  • To reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
  • As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

Limitations of Use:

  • Not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients.
  • Not recommended for use to improve glycemic control in patients with type 2 diabetes mellitus with an eGFR less than 30 mL/min/1.73 m2.
  • Not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of intravenous immunosuppressive therapy or greater than 45 mg of prednisone or equivalent for kidney disease. JARDIANCE is not expected to be effective in these populations.

Source: the FDA label for Jardiance (Boehringer Ingelheim Pharmaceuticals, Inc.), January 30, 2026. Full label on DailyMed 

Good to know